Paclitaxel-Coated Versus Sirolimus-Coated Eluting Balloons for Percutaneous Coronary Interventions: Pharmacodynamic Properties, Clinical Evidence, and Future Perspectives

Paclitaxel-Coated Versus Sirolimus-Coated Eluting Balloons for Percutaneous Coronary Interventions: Pharmacodynamic Properties, Clinical Evidence, and Future Perspectives

Drug-coated balloons (DCBs) have emerged as an increasingly valuable option for the treatment of coronary artery disease (CAD). Percutaneous coronary intervention (PCI) with DCBs enables the localized delivery of antiproliferative drugs directly to the target coronary lesion, avoiding the need for p...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippo Luca Gurgoglione, Mattia De Gregorio, Giorgio Benatti, Davide Donelli, Luigi Vignali, Emilia Solinas, Iacopo Tadonio, Andrea Denegri, Marco Covani, Gabriella Dallaglio, Bernardo Cortese, Giampaolo Niccoli
Formato: Artículo
Lenguaje:English
Publicado: MDPI AG 2024-11-01
Colección:Future Pharmacology
Materias:
drug-coated balloon
paclitaxel
sirolimus
angioplasty
coronary artery disease
peripheral artery disease
Acceso en línea:https://www.mdpi.com/2673-9879/4/4/41

Internet

https://www.mdpi.com/2673-9879/4/4/41

Ejemplares similares